Vaccine Therapy in Treating Patients With Stage IV Breast Cancer

Clinical trial NCT00791037 · COMPLETED

Trial details

NCT number: NCT00791037
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2008-10-01
Primary completion: 2013-07-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.